🔗 Visit the ClinicalTrials.gov page for NCT00162669
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | The tumor microenvironment in hepatocellular carcinoma: current status and therapeutic targets. | Semin Cancer Biol | 2010 | 2.07 |
| 2 | Targeted therapy for hepatocellular carcinoma: novel agents on the horizon. | Oncotarget | 2012 | 1.55 |
| 3 | Growth factor receptors and related signalling pathways as targets for novel treatment strategies of hepatocellular cancer. | World J Gastroenterol | 2008 | 1.31 |
| 4 | Efficacy, safety, and biomarkers of single-agent bevacizumab therapy in patients with advanced hepatocellular carcinoma. | Oncologist | 2012 | 0.90 |
| 5 | Targeting the tumor stroma in hepatocellular carcinoma. | World J Hepatol | 2015 | 0.86 |
| 6 | Targeted therapies in the treatment of advanced hepatocellular carcinoma. | Clin Med Insights Oncol | 2013 | 0.83 |